Page last updated: 2024-08-23

lonidamine and Prostatic Neoplasms

lonidamine has been researched along with Prostatic Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glickson, JD; Heitjan, DF; Leeper, DB; Nath, K; Nelson, DS; Zhou, R	1
Bloch, WE; Block, NL; Ferrell, SM; Lokeshwar, BL	1
Boccardo, F; Decensi, A; Guarneri, D; Martorana, G; Oneto, F; Pace, M	1
Aitken, SE; Futter, NG; Irvine, AH; Moors, DE; Stewart, DJ	1

Trials

2 trial(s) available for lonidamine and Prostatic Neoplasms

Article	Year
Phase II study with lonidamine in the treatment of hormone-refractory prostatic cancer patients. Tumori, 1992, Apr-30, Volume: 78, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Drug Evaluation; Humans; Indazoles; Male; Middle Aged; Prostatic Neoplasms	1992
Phase II study of lonidamine in metastatic prostatic carcinoma. Investigational new drugs, 1991, Volume: 9, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Drug Evaluation; Humans; Indazoles; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms	1991

Other Studies

2 other study(ies) available for lonidamine and Prostatic Neoplasms

Article	Year
Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin. NMR in biomedicine, 2015, Volume: 28, Issue:3 Topics: Acids; Adenosine Triphosphate; Animals; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Synergism; Energy Metabolism; Female; Humans; Hydrogen-Ion Concentration; Indazoles; Intracellular Space; Magnetic Resonance Spectroscopy; Male; Mice, Nude; Monocarboxylic Acid Transporters; Ovarian Neoplasms; Prostatic Neoplasms; Symporters; Xenograft Model Antitumor Assays	2015
Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma. The Prostate, 1994, Volume: 24, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Chemotherapy, Adjuvant; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Hot Temperature; Hyperthermia, Induced; Indazoles; Male; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Tumor Cells, Cultured	1994

Article

Year

Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.

NMR in biomedicine, 2015, Volume: 28, Issue:3

Topics: Acids; Adenosine Triphosphate; Animals; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Synergism; Energy Metabolism; Female; Humans; Hydrogen-Ion Concentration; Indazoles; Intracellular Space; Magnetic Resonance Spectroscopy; Male; Mice, Nude; Monocarboxylic Acid Transporters; Ovarian Neoplasms; Prostatic Neoplasms; Symporters; Xenograft Model Antitumor Assays

2015

Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma.

The Prostate, 1994, Volume: 24, Issue:3

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Chemotherapy, Adjuvant; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Hot Temperature; Hyperthermia, Induced; Indazoles; Male; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Tumor Cells, Cultured

1994